Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

ClinicalTrials.gov ID: NCT00385515

Public ClinicalTrials.gov record NCT00385515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Efficacy of SNX-1012 in Reducing the Duration and Severity of Ulcerative Oral Mucositis in Patients Receiving Cytotoxic Chemotherapy for Breast or Lung Cancer

Study identification

NCT ID
NCT00385515
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mucosal Therapeutics
Industry
Enrollment
81 participants

Conditions and interventions

Interventions

  • SNX-1012 (meclocycline sulfosalicylate) Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Apr 30, 2008
Completion
Jun 30, 2008
Last update posted
May 6, 2009

2006 – 2008

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Desert Hematology Oncology Medical Group Rancho Mirage California 92270
Bridgeport Hospital Bridgeport Connecticut 06610
Eastern Connecticut Hematology & Oncology Associates Norwich Connecticut 06360
Florida Research Cancer Institute Davie Florida 33328
Park Nicollet Clinic Saint Louis Park Minnesota 55416
Capitol Comprehensive Cancer Care Clinic Jefferson City Missouri 65109
Cancer Specialists of South Texas Corpus Christi Texas 78412
Cancer Outreach Associates Abingdon Virginia 24211
Morgantown Internal Medicine Group Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00385515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00385515 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →